Skip to main content
SpringerLink
Log in

Isolation and antifungal sensitivity to Candida isolates in young females

  • Research Article
  • Published:
Central European Journal of Medicine

Abstract

A survey of 104 sexually active young females tested on on cervico-vaginal swabs showed that 26 of the females (25%) had vulvovaginal candidiasis with a species distribution of Candida isolates accounting for 13 (50%) with C. albicans, 6 (23%) with C. glabrata, 1 (4%) with C. krusei, and 6 (23%) with C. tropicalis. Of the 26 (25 %) subjects that were positive for VVC, 8 (7.8 %) were symptomatic and 18 (18.8 %) were asymptomatic. However, distribution among different age groups revealed an increase in the 23–27 age group. The comparative analysis of sensitivity of the given fungi to the number of antimycotic preparations used revealed the following: in fluconazole, 2 (7.8%) isolates were sensitive, 5 (19.2%) were susceptible and dose dependent, and 19 (73%) were resistant. For voriconazole, 4 (18.4%) isolates were sensitive, 6 (23.1%) were susceptible and dose dependent, and 16 (61.5%) were resistant. For nystatin, 5 (19.2%) isolates were sensitive, 10 (38.5%) were susceptible and dose dependent, and 11 (42.3%) were resistant. It appears that Candida isolates have a variable resistance response, but 19 (73%) had maximum resistance of the isolated fungi of the genus Candida to fluconazole. Therefore, further studies on the evaluation of combination therapy should be considered for a better outcome in treatment of vulvovaginal candidiasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Nwokedi E, Omole-Ohonsi A (2007): Current Clinical Review of Vulvovaginal Candidiasis (VVC). Journal of Medicine and Rehabilitation: 1: 28–32

    Google Scholar 

  2. Onifade AK, Olorunfemi OB (2005): Epidemiology of Vulvo-vaginal Candidiasis in Female Patients in Ondo State Government Hospitals. International Journal of Food, Agriculture and Environment: 3: 118–119

    Google Scholar 

  3. Sexually transmitted diseases treatment guidelines (2006): Centers for Disease Control and Prevention. MMWR Recomm. Rep. 55(RR-11): 1–95

    Google Scholar 

  4. Sobel J, Chaim W, Nagappan V, Leaman D (2003): Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine. Am J Obstet Gynecol 189: 1:297–300

    Article  CAS  Google Scholar 

  5. Sobel JD (1998): Vulvovaginitis due to Candida glabrata. An emerging problem. Mycoses 41(suppl. 2): 18–22

    Article  PubMed  Google Scholar 

  6. Gygax S.E, Vermitsky JP, Chadwick SG, JS Matthew, J A. Zimmerman, E Mordechai, M E. Adelson, 3 and J P. Trama: Antifungal Resistance of Candida glabrata, Vaginal Isolates, and Development of a Quantitative Reverse Transcription-PCR-Based Azole Susceptibility Assay Antimicrobial Agents and Chemotherapy, 2008: 52(9): 3424–3426

    CAS  Google Scholar 

  7. Ribeiro M, Dietze R, Paula C, Da-Matta D, Colombo A (2000): Susceptibility profile of vaginal yeast isolates from Brazil. Mycopathologia 15: 5–10

    Google Scholar 

  8. Arthington-Skaggs B, Motley M, Warnocks D, Morrison C (2000): Comparative Evaluation of PASCO and National Committee for Clinical Laboratory Standards M-27-A Broth Microdilution Methods for Antifungal Drug Susceptibility Testing of Yeast. J. Clin. Microbiol. 38: 2254–2260.

    CAS  PubMed  Google Scholar 

  9. Clinical Laboratory Standards Institute (2007): Reference Method for Disc diffusion Antifungal Susceptibility of yeasts Approved standard M-44-A. CLSI, Villanova, PA, USA

    Google Scholar 

  10. Howard L (1991): Epidemiology of Vagintis. American journal of Obstetrics and Gynaecology, 165: 1168–1176

    Google Scholar 

  11. Enweani IB, Ogbonna CI, Kozak W (1987): The incidence of candidiasis amongst the asymptomatic female students of the University of Jos, Nigeria. Mycopathologia. 99: 123–141

    Article  Google Scholar 

  12. Ako-Nai AK, Kassim OO, Adeniram MO, Taiwo O (1993): A study of urinary tract infections at Ile lfe, Nigeria. East African Med J. 70: 19–14

    Google Scholar 

  13. Vermitsky JP, J Matthew. G. S. Sean. J. P. Chadwick. M. E Trama, A, E Mordechai and S.E. Gygax (2009): A Survey of Vaginal-flora Candida species of Different Age Groups Using species-specific PCR Detection. J. Clin. Microbiol. doi:10.1128/JCM.02485-07

  14. Watson C and Calabretto H (2007): Comprehensive review of conventional and non-conventional methods of management of recurrent vulvovaginal candidiasis. Austr. J Obstet Gynecol. 47: 262–272

    Article  Google Scholar 

  15. Solanki A, Mathur D, Joshi K (1983): Bacterial, fungal and parasitic flora in vaginitis. J Indian Med Assoc 1983; 81: 151–153

    CAS  PubMed  Google Scholar 

  16. Holland J, Young M, Lee O, Chen S (2003): Vulvovaginal carriage of yeasts other than Candida albicans. Sex Transm Infect 2003; 79: 249–250

    Article  CAS  PubMed  Google Scholar 

  17. McCormack WM, Starko KM, Zinne SH (1998): Symptoms associated with vaginal colonization with yeast. Am. J. Obstet. Gynecol. 158: 31–33

    Google Scholar 

  18. Enweani IB, Gugnani H, Okobia R, Roseline Okobia, Ojo SB (2001). Effects of contraceptives on the prevalence of vaginal colonization with Candida species in Edo State. Microbiol 18: 171–173

    CAS  Google Scholar 

  19. Kikani BA, Kikani KM, Pathak SJ (2008): Effects of chemically synthesized azole compounds on clinical isolates of Vaginal Candidiasis, in comparison with commercially available drugs. The internet journal of Microbiology. 4–2

  20. Okungbowa FI, Isikhumhen SO, Dede PO (2003): The distribution frequency of Candida species in the genitourinary tract among symptomatic individuals in Nigerian Cities. Micrologia 20: 60–63

    Google Scholar 

  21. Koutsoukou A, Stylianakis A, Tsiplakou S, Tachtatzis M., Tsakona E., Vourtsi A., Sideri A (2005): A 3-year study of resistance of candida pathogens obtained from patients with fungemia with emphasis to new antifungal agents. Athens Med J. p 1228

  22. Cruz O, (2003): Species distribution and antifungal susceptibility profile of Candida spp. Bloodstream isolates from Latin American Hospitals. J. Clin. Microbiol; 98: 401–5

    Google Scholar 

  23. Ferris D, Nyorjesy P, Sobel J, Soper D, Pavletio A, Litaker M (2002): Over the counter antifungal drug misuse associated with patient diagnosed vulvovaginal candidiasis. Obstet Gynecool: 99: 419–425

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Microbiology and Parasitology, PMB, 4400, Osogbo, Nigeria

    Y. O. Adesiji

  2. Department of Biomedical Science, College of Health Sciences, Ladoke Akintola University of Technology, PMB, 4400, Osogbo, Nigeria

    N. Ndukwe & B. M. Okanlawon

Authors
  1. Y. O. Adesiji
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Ndukwe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. M. Okanlawon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y. O. Adesiji.

About this article

Cite this article

Adesiji, Y.O., Ndukwe, N. & Okanlawon, B.M. Isolation and antifungal sensitivity to Candida isolates in young females. cent.eur.j.med 6, 172–176 (2011). https://doi.org/10.2478/s11536-010-0071-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11536-010-0071-0

Keywords

Search

Navigation